SULJE VALIKKO

avaa valikko

Lori J. Goldstein (ed.) | Akateeminen Kirjakauppa

ANTICANCER DRUG RESISTANCE : ADVANCES IN MOLECULAR AND CLINICAL RESEARCH

Anticancer Drug Resistance : Advances in Molecular and Clinical Research
Lori J. Goldstein (ed.); Robert F. Ozols (ed.)
Springer (2012)
Pehmeäkantinen kirja
172,80
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Anticancer Drug Resistance : Advances in Molecular and Clinical Research
172,80 €
Springer
Sivumäärä: 294 sivua
Asu: Pehmeäkantinen kirja
Julkaisuvuosi: 2012, 11.10.2012 (lisätietoa)
Kieli: Englanti
Tuotesarja: Cancer Treatment and Research 73
Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year. Clearly, the phenomenon of drug resistance is largely responsible for these failures and continues to be an area of active investigation.
Since the last volume in this series, we have learned that the energy-dependent drug efflux protein, p-glycoprotein, encoded by the MDR 1 gene, is a member of a family of structurally related transport polypeptides, thus allowing us to explore the relationship between structure and function. In addition to ongoing well designed clinical trials aimed at reversing MDR mediated drug resistance, the first gene therapy studies with the MDR 1 gene retrovirally transduced into human bone marrow cells are about to be initiated.
Although MDR is currently the most understood mechanism of drug resistance, we are uncovering increasing knowledge of alternative molecular and biochemical mechanisms of drug resistance to antimetabolites, cisplatin and alkylating agents and developing new strategies for circumventing such resistance.
It is clear that drug resistance is complex, and many mechanisms exist by which cancer cells may overcome the cytotoxicity of our known chemotherapeutic agents. As our understanding of each of these mechanisms expands, well designed models will be necessary to test laboratory hypotheses and determine their relationship to drug resistance in humans. It is this integration of basic science and clinical investigation that will both advance our scientific knowledge and result in the improvement of cancer therapy.


Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tilaustuote | Arvioimme, että tuote lähetetään meiltä noin 5-6 viikossa. Tilaa tuote jouluksi viimeistään 13.11.2024
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Anticancer Drug Resistance : Advances in Molecular and Clinical Research
Näytä kaikki tuotetiedot
ISBN:
9781461361299
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste